Guidelines for Non-operative Diagnostic Procedures and Reporting in Breast Cancer Screening

NHS Cancer Screening Programme Logo
Feedback and Enquires to the NHS Cancer Screening Programmes
NHS Cancer Screening
NHS Cancer Screening Press Room
NHS Breast Screening Programme
NHS Cervical Screening Programme
NHS Bowel Cancer Screening Programme
NHS Prostate Cancer Risk Management

Breast Screening Annual Review (UK)
Breast screening statistics
Breast Screening Equipment Guidance

Research Literature Online Database

Guidelines for non-operative diagnostic procedures and reporting in Breast Cancer Screening

NHSBSP Publication No 50 published June 2001

PDF 641Kb - ISBN 1 871997 44 5

Get Acrobat Reader

Non-operative diagnosis has become the norm in breast screening assessment. Until now, fine needle aspiration cytology (FNAC) has been the sampling method of choice, but the more recent introduction of automated core biopsy guns, which facilitate sampling, has led to the implementation of core biopsy in assessment units.

The purpose of this document is to update pathologists on the role and use of FNAC and core biopsy in breast screening assessment. It also details the mechanisms used to assure the quality of cytological and core biopsy diagnosis.

The document constitutes the second edition of guidelines for cytology procedures and reporting in breast cancer screening. It updates and replaces the previous guidelines published as NHSBSP Publication No 22.

Copies of NHSBSP publications are normally free of charge for staff working within the NHS, the voluntary sector and for healthcare students. To order copies or obtain details of prices and availability of publications to those outside the NHS, please contact the Department of Health publication orderline: Telephone: 0300 123 1002, Textphone: 0300 123 1003, Fax: 01623 724 524, Email orders: [email protected]

NHS Breast Cancer Screening Publications

Search this site for:
Breast Screening Publications Index

Breast screening programme index

What happens at a
breast screening unit?

What are the risks of breast screening?

Frequently Asked Questions (FAQs)

Breast awareness

Benign breast disease

DCIS (Ductal Carcinoma
in Situ)

Diethylstilbestrol (DES) exposed women

Breast cancer

Quality assurance

Training

Programme statistics

Archived statistics bulletins

Research

Publications index

Programme posters

Archive

Useful links

Home | Breast Screening | Cervical Screening | Bowel Cancer Screening | Prostate Cancer Risk Management | Screening News | Contact NHS Screening ]

The national office can be contacted at:

NHS Cancer Screening Programmes
Fulwood House
Old Fulwood Road
SHEFFIELD S10 3TH

Tel: 0114 271 1060
Fax: 0114 271 1089
E-mail: [email protected]

Press and media enquiries should be made to:

NHS Cancer Screening Press Office
100 Gray's Inn Road
London
WC1X 8AL

Tel: 020 7400 4499
Fax: 020 7400 4481
E-mail: [email protected]

breastscreen/publications/qa-08.html
site created by The Net Effect
©NHS Cancer Screening Programmes